IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.360
-0.040 (-2.86%)
Oct 2, 2026, 2:57 PM EDT - Market open
IN8bio Market Cap
IN8bio has a market cap or net worth of $13.41 million as of October 2, 2026. Its market cap has increased by 30.68% in one year.
Market Cap
13.41M
Enterprise Value
-2.37M
1-Year Change
30.68%
Ranking
Category
Stock Price
$1.36
ChartMarket Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $13.41M, a decrease of -92.85%. That is a compound annual growth rate of -39.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 13.41M | -41.30% |
| Dec 31, 2025 | 22.84M | 22.52% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Niki BioSolutions | 13.78M |
| Passage Bio | 13.76M |
| Tempest Therapeutics | 13.40M |
| Lisata Therapeutics | 13.38M |
| AEON Biopharma | 13.34M |
| Vyome Holdings | 13.34M |
| Pluri | 13.09M |
| Daré Bioscience | 13.06M |